[Lymphocyte subset change during cancer chemotherapy on patients with gastrointestinal, lung and hematopoietic malignancies]

Gan To Kagaku Ryoho. 1990 Mar;17(3 Pt 2):475-81.
[Article in Japanese]

Abstract

Lymphocyte subsets measured by Ortho-mune on OKT 3, OKT 4A, OKT 8, OKT 10, OKT 11, OKM1, OKB 7, OKB 2 and OKDR were observed before and after chemotherapy on patients with gastrointestinal, lung and hematopoietic malignancies. Almost all patients showed decreased T-cell function expressed by OKT 11 or OKT 3 and suppressor, helper T-cell function expressed by OKT 8 and OKT 4A. In some patients improvement of T-cell function were observed with clinical response and in such cases life span seemed to be longer as expected, and it is supposed that during cancer chemotherapy improvement of T-cell function expressed by OKT series may be important prognostic factors.

Publication types

  • Case Reports
  • Comparative Study
  • English Abstract

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Female
  • Gastrointestinal Neoplasms / blood
  • Gastrointestinal Neoplasms / drug therapy
  • Gastrointestinal Neoplasms / immunology*
  • Humans
  • Leukemia / blood
  • Leukemia / drug therapy
  • Leukemia / immunology*
  • Leukocyte Count
  • Lung Neoplasms / blood
  • Lung Neoplasms / drug therapy
  • Lung Neoplasms / immunology*
  • Lymphocytes / immunology*
  • Lymphoma / blood
  • Lymphoma / drug therapy
  • Lymphoma / immunology*
  • Male
  • Middle Aged
  • Prognosis
  • Remission Induction